CINECA IRIS Institutional Research Information System

PRETE, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.059
AS - Asia 1.622
EU - Europa 972
SA - Sud America 298
Continente sconosciuto - Info sul continente non disponibili 113
AF - Africa 96
OC - Oceania 1
Totale 6.161
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.988
SG - Singapore 603
CN - Cina 428
IT - Italia 320
BR - Brasile 249
HK - Hong Kong 225
DE - Germania 148
VN - Vietnam 146
SE - Svezia 111
FR - Francia 75
AT - Austria 65
GB - Regno Unito 49
FI - Finlandia 46
JP - Giappone 35
CA - Canada 33
BG - Bulgaria 32
CI - Costa d'Avorio 30
IN - India 29
BD - Bangladesh 23
KR - Corea 22
SN - Senegal 21
AR - Argentina 20
RU - Federazione Russa 20
PL - Polonia 19
TR - Turchia 19
MA - Marocco 18
MX - Messico 18
EE - Estonia 15
NL - Olanda 15
ZA - Sudafrica 13
ES - Italia 11
IQ - Iraq 10
SA - Arabia Saudita 10
UZ - Uzbekistan 10
ID - Indonesia 9
PK - Pakistan 9
UA - Ucraina 9
EC - Ecuador 7
CL - Cile 6
CZ - Repubblica Ceca 6
CO - Colombia 5
IE - Irlanda 5
JO - Giordania 5
MG - Madagascar 5
PH - Filippine 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
GR - Grecia 4
KE - Kenya 4
LT - Lituania 4
MY - Malesia 4
BE - Belgio 3
GT - Guatemala 3
JM - Giamaica 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
OM - Oman 3
TT - Trinidad e Tobago 3
CR - Costa Rica 2
HN - Honduras 2
IL - Israele 2
MC - Monaco 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
PY - Paraguay 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GD - Grenada 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
PR - Porto Rico 1
SK - Slovacchia (Repubblica Slovacca) 1
VG - Isole Vergini Britanniche 1
ZM - Zambia 1
Totale 6.048
Salva come PNG Salva come JPEG
Città #
Dallas 562
Ashburn 364
Singapore 360
San Jose 330
Hong Kong 220
Santa Clara 170
Chandler 131
Shanghai 92
New York 90
Munich 88
Los Angeles 83
Beijing 65
Vienna 61
Pisa 57
Milan 53
Council Bluffs 49
Fairfield 49
Boardman 46
Ho Chi Minh City 46
Hefei 34
Sofia 32
Tokyo 32
Abidjan 30
Hanoi 30
Houston 30
Frankfurt am Main 27
Lauterbourg 27
Woodbridge 27
Florence 26
Helsinki 26
Redondo Beach 26
São Paulo 26
Buffalo 25
Rome 24
Atlanta 23
Seoul 22
Cambridge 21
Dakar 21
Princeton 21
Orem 20
Lawrence 19
Seattle 19
Wilmington 19
London 17
Turku 17
Medford 15
Warsaw 14
Brooklyn 12
Columbus 12
Denver 12
Phoenix 12
Poplar 12
Casablanca 11
Ogden 11
Chicago 10
Johannesburg 10
Montreal 10
Cascina 9
Düsseldorf 9
Lucca 9
Nuremberg 9
San Diego 9
Serra 9
Tashkent 9
Washington 9
Belo Horizonte 8
Fuzhou 8
Istanbul 8
Baltimore 7
Boston 7
Memphis 7
Stockholm 7
Amsterdam 6
Bologna 6
Changchun 6
Da Nang 6
Jeddah 6
Mexico City 6
Mumbai 6
Paris 6
Quanzhou 6
Toronto 6
Amman 5
Antananarivo 5
Baghdad 5
Bremen 5
Chiesina Uzzanese 5
Hải Dương 5
Modena 5
Presidente Prudente 5
Redmond 5
Rio de Janeiro 5
San Francisco 5
Turin 5
Vancouver 5
Wroclaw 5
Ankara 4
Ann Arbor 4
Baku 4
Caracas 4
Totale 3.968
Salva come PNG Salva come JPEG
Nome #
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations 215
Pre- And Post-Operative Circulating Tumoral Dna In Patients With Medullary Thyroid Carcinoma 191
18F-DOPA-PET/CT role in medullary thyroid cancer patients with biochemical incomplete response 183
Systemic treatment of advanced, metastatic, medullary thyroid carcinoma 168
GENETIC LANDSCAPE OF SOMATIC MUTATIONS IN A LARGE COHORT OF SPORADIC MEDULLARY THYROID CARCINOMAS STUDIED BY NEXT GENERATION TARGETED SEQUENCING 166
MON-490 Calcitonin-Based Thyroidectomy Is a Safe Approach in Patients with Germline RET Mutation and Permits to Delay Surgery in Children 165
Chromosomal alterations in sporadic medullary thyroid carcinoma and correlation with outcome 164
Impact of Advanced Age on the Clinical Presentation and Outcome of Sporadic Medullary Thyroid Carcinoma 159
Clinical evolution of sporadic medullary thyroid carcinoma with biochemical incomplete response after initial treatment 158
OR21-01 Pre-Operative Calcitonin Value as a Predictive Factor of Cancer Related Death in Sporadic Medullary Thyroid Carcinoma 158
Body Mass Index and Sporadic Medullary Thyroid Cancer: Insights from a Large Series 155
Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone 147
Bilateral testicular metastases of medullary thyroid carcinoma in an adult male with multiple endocrine neoplasia 2A syndrome: case report and review of literature 141
Assessing mPTC Progression during Active Surveillance: Volume or Diameter Increase? 139
Molecular profiling of low-risk papillary thyroid carcinoma (mPTC) on active surveillance 136
Ret mutated C-cells proliferate more rapidly than non-mutated neoplastic cells 135
RET Copy Number Alteration in Medullary Thyroid Cancer Is a Rare Event Correlated with RET Somatic Mutations and High Allelic Frequency 134
Redefining the prevalence of different clinical variants in MEN2A and their correlation with RET germline mutations: a single-center series and experience 131
Effect of Pregnancy and Menopause on Micropapillary Thyroid Carcinomas During Active Surveillance 131
Chylous effusions in advanced medullary thyroid cancer patients treated with selpercatinib 131
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center 131
The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma 128
Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature 128
Active surveillance in differentiated thyroid cancer: a strategy applicable to all treatment categories response 122
Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer 122
Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer 119
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 119
Firm mass in thyroid of an elderly patient: Not always cancer 118
Hypothesizing a role of ret hyperactivation on weight control in patients with type 2A multiple endocrine neoplasia (MEN2A) 117
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments 115
NF1 Gene Inactivation Acts as Tumor Driver in RET/RAS Negative Medullary Thyroid Carcinomas 114
Use of non-nutritive-sweetened soft drink and risk of gestational diabetes 112
Correction to: Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer (Journal of Endocrinological Investigation, (2021), 44, 10, (2139-2151), 10.1007/s40618-020-01491-3) 107
Management of patients with extensive locally advanced thyroid cancer: results of multimodal treatments 106
Significant response of medullary thyroid cancer choroidal metastases to highly selective RET inhibitor selpercatinib: a case report 105
The challenge of the differential diagnosis between brown tumors and metastases in parathyroid carcinoma: a case report 101
Ultrasound features and risk stratification systems to identify medullary thyroid carcinoma 100
MULTIFOCALITY AND BILATERALITY IN MEDULLARY THYROID CANCER: BASIS FOR A PROOF-OF-CONCEPT SAFETY OF LOBECTOMY 97
BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review 96
Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib 94
Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination 94
Inflammation-based scores in patients with pheochromocytoma 92
Insights into Ultrasound Features and Risk Stratification Systems in Pediatric Patients with Thyroid Nodules 88
Sporadic Medullary Thyroid Carcinoma: Towards a Precision Medicine 81
Usefulness of second 131I treatment in biochemical persistent differentiated thyroid cancer patients 76
Somatic RET Indels in Sporadic Medullary Thyroid Cancer: Prevalence and Response to Selpercatinib 67
State of the Art in 3D Culture Models Applied to Thyroid Cancer 63
Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer 62
Liquid Biopsy-Based RET Mutation Profiling to Guide RET Inhibitor Treatment in Sporadic Medullary Thyroid Carcinoma May Be Useful in Cases with High Tumor Burden and Progressive Disease 45
Calcitonin Thresholds for Prediction of Medullary Thyroid Carcinoma and its Clinical Response in MEN2A Gene Carriers 31
Molecular Profile of Advanced Radioiodine-refractory Thyroid Cancer and Response to Lenvatinib Treatment 25
Prevalence and genetics of "de novo" MEN2 syndromes 23
Comparison of pre-operative calcitonin, FNAC, and ultrasound risk stratification systems in patients with medullary thyroid carcinoma 23
null 19
A large series of patients with anaplastic thyroid cancer managed in a tertiary referral center 9
Impairment in the hypothalamic-pituitary-gonadal axis in males with medullary thyroid carcinoma treated with selpercatinib 5
Totale 6.161
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.246
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.246
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022167 0 0 4 0 26 22 13 9 11 12 16 54
2022/2023452 40 49 41 38 51 51 2 41 96 3 32 8
2023/2024343 17 29 54 26 42 66 21 3 5 9 27 44
2024/20251.562 21 58 28 85 160 114 167 86 156 172 199 316
2025/20262.979 202 474 394 305 303 167 374 92 155 245 109 159
2026/2027470 95 375 0 0 0 0 0 0 0 0 0 0
Totale 6.161